Dr. Iwamoto is a professor at the UCLA Department of Radiation Oncology. He obtained his PhD at UCLA in 1990. A central component of his research is the biological mechanisms of radiation response, especially carcinogenesis, and their exploitation in the improvement of radiotherapy.
1: Bassler N, Alsner J, Beyer G, DeMarco JJ, Doser M, Hajdukovic D, Hartley O, Iwamoto KS, Jäkel O, Knudsen HV, Kovacevic S, Møller SP, Overgaard J, Petersen JB, Solberg TD, Sørensen BS, Vranjes S, Wouters BG, Holzscheiter MH. Antiproton radiotherapy. Radiother Oncol. 2008 Jan;86(1):14-9. doi: 10.1016/j.radonc.2007.11.028. Epub 2007 Dec 26. PMID: 18158194.
2: McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M, Liao YP. A sense of danger from radiation. Radiat Res. 2004 Jul;162(1):1-19. doi: 10.1667/rr3196. PMID: 15222781.
3: Micewicz ED, Damoiseaux RD, Deng G, Gomez A, Iwamoto KS, Jung ME, Nguyen C, Norris AJ, Ratikan JA, Ruchala P, Sayre JW, Schaue D, Whitelegge JP, McBride WH. Classes of Drugs that Mitigate Radiation Syndromes. Front Pharmacol. 2021 May 18;12:666776. doi: 10.3389/fphar.2021.666776. PMID: 34084139; PMCID: PMC8167044.
4: Schaue D, Micewicz ED, Ratikan JA, Iwamoto KS, Vlashi E, McDonald JT, McBride WH. NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice. Antioxidants (Basel). 2022 Aug 25;11(9):1649. doi: 10.3390/antiox11091649. PMID: 36139722; PMCID: PMC9495793.
5: McBride WH, Iwamoto KS, Syljuasen R, Pervan M, Pajonk F. The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene. 2003 Sep 1;22(37):5755-73. doi: 10.1038/sj.onc.1206676. PMID: 12947384.
6: Iwamoto KS, Sandstrom RE, Bryan M, Liu Y, Elgart SR, Sheng K, Steinberg ML, McBride WH, Low DA. Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy. Adv Radiat Oncol. 2021 Jan 16;6(3):100645. doi: 10.1016/j.adro.2021.100645. PMID: 33748547; PMCID: PMC7966835.
7: Schaue D, Ratikan JA, Iwamoto KS. Cellular autofluorescence following ionizing radiation. PLoS One. 2012;7(2):e32062. doi: 10.1371/journal.pone.0032062. Epub 2012 Feb 22. PMID: 22384140; PMCID: PMC3284545.
8: Micewicz ED, Kim K, Iwamoto KS, Ratikan JA, Cheng G, Boxx GM, Damoiseaux RD, Whitelegge JP, Ruchala P, Nguyen C, Purbey P, Loo J, Deng G, Jung ME, Sayre JW, Norris AJ, Schaue D, McBride WH. 4-(Nitrophenylsulfonyl)
9: Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1306-10. doi: 10.1016/j.ijrobp.2011.09.049. Epub 2011 Dec 28. PMID: 22208977; PMCID: PMC3337972.
10: Kachikwu EL, Iwamoto KS, Liao YP, DeMarco JJ, Agazaryan N, Economou JS, McBride WH, Schaue D. Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1128-35. doi: 10.1016/j.ijrobp.2010.09.034. Epub 2010 Nov 17. PMID: 21093169; PMCID: PMC3117954.
11: MacKenzie C, Iwamoto KS, Smith K. University of California Replacement of Cesium Irradiators with Alternative Technologies. Health Phys. 2020 Feb;118(2):209-214. doi: 10.1097/HP.0000000000001160. PMID: 31869317.
12: Holzscheiter MH, Bassler N, Agazaryan N, Beyer G, Blackmore E, DeMarco JJ, Doser M, Durand RE, Hartley O, Iwamoto KS, Knudsen HV, Landua R, Maggiore C, McBride WH, Møller SP, Petersen J, Skarsgard LD, Smathers JB, Solberg TD, Uggerhøj UI, Vranjes S, Withers HR, Wong M, Wouters BG. The biological effectiveness of antiproton irradiation. Radiother Oncol. 2006 Dec;81(3):233-42. doi: 10.1016/j.radonc.2006.09.012. Epub 2006 Oct 27. PMID: 17069916.
13: Pervan M, Iwamoto KS, McBride WH. Proteasome structures affected by ionizing radiation. Mol Cancer Res. 2005 Jul;3(7):381-90. doi: 10.1158/1541-7786.MCR-05-0032. PMID: 16046549.
14: Rogers CJ, Lukaszewicz AI, Yamada-Hanff J, Micewicz ED, Ratikan JA, Starbird MA, Miller TA, Nguyen C, Lee JT, Olafsen T, Iwamoto KS, McBride WH, Schaue D, Menon N. Identification of miRNA signatures associated with radiation-induced late lung injury in mice. PLoS One. 2020 May 11;15(5):e0232411. doi: 10.1371/journal.pone.0232411. PMID: 32392259; PMCID: PMC7213687.
15: Micewicz ED, Iwamoto KS, Ratikan JA, Nguyen C, Xie MW, Cheng G, Boxx GM, Deriu E, Damoiseaux RD, Whitelegge JP, Ruchala PP, Avetisyan R, Jung ME, Lawson G, Nemeth E, Ganz T, Sayre JW, McBride WH, Schaue D. The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation. Radiat Res. 2019 Apr;191(4):323-334. doi: 10.1667/RR15231.1. Epub 2019 Feb 7. PMID: 30730284; PMCID: PMC6482953.
16: Clemenson GD, Lee SW, Deng W, Barrera VR, Iwamoto KS, Fanselow MS, Gage FH. Enrichment rescues contextual discrimination deficit associated with immediate shock. Hippocampus. 2015 Mar;25(3):385-92. doi: 10.1002/hipo.22380. Epub 2014 Oct 31. PMID: 25330953; PMCID: PMC4398310.
17: Iwamoto KS, Bennett LR, Norman A, Villalobos AE, Hutson CA. Linoleate produces remission in canine mycosis fungoides. Cancer Lett. 1992 May 30;64(1):17-22. doi: 10.1016/0304-3835(92)90016-o. PMID: 1596872.
18: Wang C, King CR, Kamrava M, Iwamoto KS, Chen AM, Low D, Kupelian PA, Steinberg ML. Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancer. Radiother Oncol. 2017 Apr;123(1):133-138. doi: 10.1016/j.radonc.2017.01.009. Epub 2017 Feb 7. PMID: 28187996.
19: Nakashiba T, Cushman JD, Pelkey KA, Renaudineau S, Buhl DL, McHugh TJ, Rodriguez Barrera V, Chittajallu R, Iwamoto KS, McBain CJ, Fanselow MS, Tonegawa S. Young dentate granule cells mediate pattern separation, whereas old granule cells facilitate pattern completion. Cell. 2012 Mar 30;149(1):188-201. doi: 10.1016/j.cell.2012.01.046. Epub 2012 Feb 23. PMID: 22365813; PMCID: PMC3319279.
20: Norman A, Iwamoto KS, Kagan AR, Wollin M. Radiation sensitive breast cancer patients. Radiother Oncol. 1992 Mar;23(3):196-7. doi: 10.1016/0167-8140(92)90331-n. PMID: 1574599.
21: Chen WC, McBride WH, Iwamoto KS, Barber CL, Wang CC, Oh YT, Liao YP, Hong JH, de Vellis J, Shau H. Induction of radioprotective peroxiredoxin-I by ionizing irradiation. J Neurosci Res. 2002 Dec 15;70(6):794-8. doi: 10.1002/jnr.10435. PMID: 12444601.
22: Akiyama M, Kyoizumi S, Hirai Y, Kusunoki Y, Iwamoto KS, Nakamura N. Mutation frequency in human blood cells increases with age. Mutat Res. 1995 Oct;338(1-6):141-9. doi: 10.1016/0921-8734(95)00019-3. PMID: 7565869.
23: Norman A, Mitchell JC, Iwamoto KS. A sensitive assay for 6-thioguanine- resistant lymphocytes. Mutat Res. 1988 May;208(1):17-9. doi: 10.1016/0165-7992(88)90014-0. PMID: 3367928.
24: Norman A, Bennett LR, Mead JF, Iwamoto KS. Antitumor activity of sodium linoleate. Nutr Cancer. 1988;11(2):107-15. doi: 10.1080/01635588809513977. PMID: 3362721.
25: Sha W, Ye H, Iwamoto KS, Wong KP, Wilks MQ, Stout D, McBride W, Huang SC. Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies. EJNMMI Res. 2013 Jul 10;3:51. doi: 10.1186/2191-219X-3-51. PMID: 23841937; PMCID: PMC3718724.
26: Purbey PK, Scumpia PO, Kim PJ, Tong AJ, Iwamoto KS, McBride WH, Smale ST. Defined Sensing Mechanisms and Signaling Pathways Contribute to the Global Inflammatory Gene Expression Output Elicited by Ionizing Radiation. Immunity. 2017 Sep 19;47(3):421-434.e3. doi: 10.1016/j.immuni.2017.08.017. PMID: 28930658; PMCID: PMC5661954.
27: Norman A, Ingram M, Skillen RG, Freshwater DB, Iwamoto KS, Solberg T. X-ray phototherapy for canine brain masses. Radiat Oncol Investig. 1997;5(1):8-14. doi: 10.1002/(SICI)1520-6823(1997)
28: Brush JM, Kim K, Sayre JW, McBride WH, Iwamoto KS. Imaging of radiation effects on cellular 26S proteasome function in situ. Int J Radiat Biol. 2009 Jun;85(6):483-94. doi: 10.1080/09553000902883794. PMID: 19401903; PMCID: PMC2775098.
29: Mizuno T, Iwamoto KS, Kyoizumi S, Nagamura H, Shinohara T, Koyama K, Seyama T, Hamatani K. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene. 2000 Jan 20;19(3):438-43. doi: 10.1038/sj.onc.1203343. PMID: 10656692.
30: Elgart SR, Bostani M, Mok KC, Adibi A, Ruehm S, Enzmann D, McNitt-Gray M, Iwamoto KS. Investigation of DNA Damage Dose-Response Kinetics after Ionizing Radiation Schemes Similar to CT Protocols. Radiat Res. 2015 Jun;183(6):701-7. doi: 10.1667/RR13752.1. Epub 2015 May 7. PMID: 25950819.
31: Kim K, Pollard JM, Norris AJ, McDonald JT, Sun Y, Micewicz E, Pettijohn K, Damoiseaux R, Iwamoto KS, Sayre JW, Price BD, Gatti RA, McBride WH. High- throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin Cancer Res. 2009 Dec 1;15(23):7238-45. doi: 10.1158/1078-0432.CCR-09-1964. Epub 2009 Nov 17. PMID: 19920105; PMCID: PMC2787903.
32: Mizuno T, Nagamura H, Iwamoto KS, Ito T, Fukuhara T, Tokunaga M, Tokuoka S, Mabuchi K, Seyama T. RNA from decades-old archival tissue blocks for retrospective studies. Diagn Mol Pathol. 1998 Aug;7(4):202-8. doi: 10.1097/00019606-199808000-
33: Ito T, Seyama T, Mizuno T, Hayashi T, Iwamoto KS, Dohi K, Nakamura N, Akiyama M. Induction of BCR-ABL fusion genes by in vitro X-irradiation. Jpn J Cancer Res. 1993 Feb;84(2):105-9. doi: 10.1111/j.1349-7006.1993.
34: Wang C, Kishan AU, Yu JB, Raldow A, King CR, Iwamoto KS, Chu FI, Steinberg ML, Kupelian PA. Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014). Adv Radiat Oncol. 2019 May 15;4(4):738-747. doi: 10.1016/j.adro.2019.05.003. PMID: 31673667; PMCID: PMC6817555.
35: Takahashi M, Valdes G, Hiraoka K, Inagaki A, Kamijima S, Micewicz E, Gruber HE, Robbins JM, Jolly DJ, McBride WH, Iwamoto KS, Kasahara N. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector. Cancer Gene Ther. 2014 Oct;21(10):405-410. doi: 10.1038/cgt.2014.38. Epub 2014 Oct 10. PMID: 25301172; PMCID: PMC4246057.
36: Hafer K, Iwamoto KS, Scuric Z, Schiestl RH. Adaptive response to gamma radiation in mammalian cells proficient and deficient in components of nucleotide excision repair. Radiat Res. 2007 Aug;168(2):168-74. doi: 10.1667/RR0717.1. Erratum in: Radiat Res. 2008 Apr;169(4):481. Iwamoto, Keisuke K [corrected to Iwamoto, Keisuke S]. PMID: 17638404.
37: Iwamoto KS, Norman A, Kagan AR, Wollin M, Olch A, Bellotti J, Ingram M, Skillen RG. The CT scanner as a therapy machine. Radiother Oncol. 1990 Dec;19(4):337-43. doi: 10.1016/0167-8140(90)90034-t. PMID: 2126635.
38: Liao YP, Wang CC, Butterfield LH, Economou JS, Ribas A, Meng WS, Iwamoto KS, McBride WH. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells. J Immunol. 2004 Aug 15;173(4):2462-9. doi: 10.4049/jimmunol.173.4.2462. PMID: 15294960.
39: Hafer K, Iwamoto KS, Schiestl RH. Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and bystander cell populations. Radiat Res. 2008 Apr;169(4):460-8. doi: 10.1667/RR1212.1. PMID: 18363435.
40: Mizuno T, Tokuoka S, Kishikawa M, Nakashima E, Mabuchi K, Iwamoto KS. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations. Carcinogenesis. 2006 Nov;27(11):2286-94. doi: 10.1093/carcin/bgl107. Epub 2006 Jun 15. PMID: 16777989.
41: Valdes G, Schulte RW, Ostermeier M, Iwamoto KS. The high-affinity maltose switch MBP317-347 has low affinity for glucose: implications for targeting tumors with metabolically directed enzyme prodrug therapy. Chem Biol Drug Des. 2014 Mar;83(3):266-71. doi: 10.1111/cbdd.12249. Epub 2013 Dec 26. PMID: 24131788.
42: Yano M, Asahara T, Dohi K, Mizuno T, Iwamoto KS, Seyama T. Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients. Int J Oncol. 1999 Mar;14(3):447-51. doi: 10.3892/ijo.14.3.447. PMID: 10024676.
43: Iwamoto KS, Hirai Y, Umeki S, Kusunoki Y, Kyoizumi S, Kodama T, Ohama K, Nakamura N, Akiyama M. A positive correlation between T-cell-receptor mutant frequencies and dicentric chromosome frequencies in lymphocytes from radiotherapy patients. J Radiat Res. 1994 Jun;35(2):92-103. doi: 10.1269/jrr.35.92. PMID: 7965994.
44: Iwamoto KS, Yano S, Barber CL, MacPhee DG, Tokuoka S. A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from the atomic bomb survivors. Radiat Res. 2006 Dec;166(6):870-6. doi: 10.1667/RR0585.1. PMID: 17149973.
45: Valdes G, Iwamoto KS. Re-evaluation of cellular radiosensitization by 5-fluorouracil: high-dose, pulsed administration is effective and preferable to conventional low-dose, chronic administration. Int J Radiat Biol. 2013 Oct;89(10):851-62. doi: 10.3109/09553002.2013.797620. Epub 2013 May 15. PMID: 23607451.
46: Valdes G, Robinson C, Lee P, Morel D, Low D, Iwamoto KS, Lamb JM. Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer. Med Dosim. 2015 Spring;40(1):64-9. doi: 10.1016/j.meddos.2014.10.002. Epub 2014 Dec 24. PMID: 25542785.
47: Wang CC, Liao YP, Mischel PS, Iwamoto KS, Cacalano NA, McBride WH. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Res. 2006 Jul 1;66(13):6756-62. doi: 10.1158/0008-5472.CAN-06-0185. PMID: 16818651.
48: Kim K, Brush JM, Watson PA, Cacalano NA, Iwamoto KS, McBride WH. Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation. Mol Cancer Res. 2008 Mar;6(3):426-34. doi: 10.1158/1541-7786.MCR-07-0313. PMID: 18337449; PMCID: PMC2877368.
49: Mizuno T, Kyoizumi S, Suzuki T, Iwamoto KS, Seyama T. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis. Oncogene. 1997 Sep 18;15(12):1455-60. doi: 10.1038/sj.onc.1201313. PMID: 9333021.
50: Iwamoto KS, Fujii S, Kurata A, Suzuki M, Hayashi T, Ohtsuki Y, Okada Y, Narita M, Takahashi M, Hosobe S, Doishita K, Manabe T, Hata S, Murakami I, Hata S, Itoyama S, Akatsuka S, Ohara N, Iwasaki K, Akabane H, Fujihara M, Seyama T, Mori T. p53 mutations in tumor and non-tumor tissues of thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver. Carcinogenesis. 1999 Jul;20(7):1283-91. doi: 10.1093/carcin/20.7.1283. PMID: 10383902.
51: Iwamoto KS, Cochran ST, Winter J, Holburt E, Higashida RT, Norman A. Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors. Radiother Oncol. 1987 Feb;8(2):161-70. doi: 10.1016/s0167-8140(87)80170-6. PMID: 3562895.
52: Umeki S, Kusunoki Y, Cologne JB, Iwamoto KS, Hirai Y, Seyama T, Ohama K, Kyoizumi S. Lifespan of human memory T-cells in the absence of T-cell receptor expression. Immunol Lett. 1998 Jun;62(2):99-104. doi: 10.1016/s0165-2478(98)00037-6. PMID: 9698105.
53: Iwamoto KS, Barber CL. Radiation-induced posttranscriptional control of M6P/IGF2r expression in breast cancer cell lines. Mol Carcinog. 2007 Jul;46(7):497-502. doi: 10.1002/mc.20303. PMID: 17295243.
54: Liao YP, Wang CC, Schaue D, Iwamoto KS, McBride WH. Local irradiation of murine melanoma affects the development of tumour-specific immunity. Immunology. 2009 Sep;128(1 Suppl):e797-804. doi: 10.1111/j.1365-2567.2009.
55: Norman A, Iwamoto KS, Cochran ST. Iodinated contrast agents for brain tumor localization and radiation dose enhancement. Invest Radiol. 1991 Nov;26 Suppl 1:S120-1; discussion S125-8. doi: 10.1097/00004424-199111001-
56: Solberg TD, Iwamoto KS, Norman A. Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours. Phys Med Biol. 1992 Feb;37(2):439-43. doi: 10.1088/0031-9155/37/2/010. PMID: 1553392.
57: Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, Cherstovoy ED, Satow Y, Takeichi N, Dohi K, et al. Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet. 1994 Jul 23;344(8917):259. doi: 10.1016/s0140-6736(94)93024-4. PMID: 7913169.
58: Iwamoto KS, Mizuno T, Seyama T, Kyoizumi S. Mutant p53: epigenetic mutator of the T-cell receptor via induction of methylation. Mol Carcinog. 1999 Jun;25(2):113-21. doi: 10.1002/(sici)1098-2744(
59: Iwamoto KS, Mizuno T, Kurata A, Masuzawa M, Mori T, Seyama T. Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancers. Hum Pathol. 1998 Apr;29(4):412-6. doi: 10.1016/s0046-8177(98)90126-5. PMID: 9563795.
60: Ito T, Seyama T, Kyoizumi S, Teraoka S, Iwamoto KS, Mizuno T, Tsuyama N, Asahara T, Dohi K, Akiyama M. The usefulness of severe combined immunodeficiency (SCID) mice to study human carcinogenesis. Cancer Lett. 1995 Jan 6;88(1):113-7. doi: 10.1016/0304-3835(94)03622-p. PMID: 7850767.
61: Iwamoto KS, McBride WH. Production of 13-hydroxyoctadecadienoic acid and tumor necrosis factor-alpha by murine peritoneal macrophages in response to irradiation. Radiat Res. 1994 Jul;139(1):103-8. PMID: 8016298.
62: Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, Akiyama M. In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res. 1993 Jul 1;53(13):2940-3. PMID: 8319199.
63: Iwamoto KS. Tracking the errant cell after the atomic bombings: what went wrong? Health Phys. 2003 Jul;85(1):81-3. doi: 10.1097/00004032-200307000-
64: Iwamoto KS, Mizuno T, Tokuoka S, Mabuchi K, Seyama T. Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivors. J Natl Cancer Inst. 1998 Aug 5;90(15):1167-8. doi: 10.1093/jnci/90.15.1167. PMID: 9701367.
65: Iwamoto KS, Norman A, Freshwater DB, Ingram M, Skillen RG. Diagnosis and treatment of spontaneous canine brain tumors with a CT scanner. Radiother Oncol. 1993 Jan;26(1):76-8. doi: 10.1016/0167-8140(93)90030-c. PMID: 8438091.
66: Hafer K, Scuric Z, Iwamoto KS, Schiestl RH. Point-source irradiation with eccentric rotation causes inhomogeneous dose distribution. Radiat Res. 2006 May;165(5):616-20. doi: 10.1667/RR3524.1. PMID: 16669744.
67: Ito T, Seyama T, Hayashi T, Mizuno T, Iwamoto KS, Tsuyama N, Dohi K, Nakamura N, Akiyama M. HaeIII polymorphism in intron 1 of the human p53 gene. Hum Genet. 1994 Feb;93(2):222. doi: 10.1007/BF00210619. PMID: 8112754.
68: Tsuyama N, Ide T, Noda A, Iwamoto KS, Mizuno T, Kyoizumi S, Seyama T. X-rays induce dose-dependent and cell cycle-independent accumulation of p21(sdi1/WAF1). Hiroshima J Med Sci. 2001 Mar;50(1):1-7. PMID: 11314855.
69: Iwamoto KS, Mizuno T, Ito T, Akiyama M, Takeichi N, Mabuchi K, Seyama T. Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am J Pathol. 1996 Aug;149(2):399-406. PMID: 8701980; PMCID: PMC1865296.
70: Iwamoto KS, Mizuno T, Ito T, Tsuyama N, Kyoizumi S, Seyama T. Gain-of- function p53 mutations enhance alteration of the T-cell receptor following X-irradiation, independently of the cell cycle and cell survival. Cancer Res. 1996 Sep 1;56(17):3862-5. PMID: 8752146.
r following X-irradiation, independently of the cell cycle and cell survival. Cancer Res. 1996 Sep 1;56(17):3862-5. PMID: 8752146.
Publications